CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - EUR (€) € in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenue
Research and development	€ 11	€ 0	€ 28	€ 0
Grants	134	128	389	128
Total revenue	145	128	417	128
Expenses
Research and development	252	210	574	425
General and administrative	296	249	621	527
Other (income) expense	(47)	(23)	59	43
Total expenses	501	436	1,254	995
Operating loss	(356)	(308)	(837)	(867)
Interest expense	676	667	1,351	1,333
Loss before income tax provision	(1,032)	(975)	(2,188)	(2,200)
Income tax provision	1	(7)	(7)	(10)
Net loss	(1,031)	(982)	(2,195)	(2,210)
Other Comprehensive Income
Foreign currency translation adjustment	0	1	7	6
Comprehensive loss	€ (1,031)	€ (981)	€ (2,188)	€ (2,204)
Basic and dilutive earnings per share	€ (0.00)	€ (0.00)	€ (0.01)	€ (0.01)
Weighted average number of shares used in per share calculations	303,757,622	303,757,622	303,757,622	303,757,622